2026 Advances and Ongoing Challenges in HR-positive, HER2-Negative Metastatic Breast Cancer
Breast cancer is the most commonly diagnosed cancer among U.S. women, with HR-positive/HER2-negative disease predominating. Despite advances that have improved outcomes, incidence and resistance remain...
